{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:52:53Z","timestamp":1791420773451,"version":"4.3.3"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T00:00:00Z","timestamp":1778371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009651","name":"Parkinson's Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009651","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003355","name":"Garvan Institute of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003355","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001774","name":"The University of Sydney","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008487","name":"Cure Parkinson's Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008487","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, &amp; Immunity - Health"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bbih.2026.101257","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:54:51Z","timestamp":1778766891000},"page":"101257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Reduced serum interleukin-2 associates with higher motor severity and along with CD4 T cell alterations may be an early event in isolated REM Sleep Behaviour Disorder"],"prefix":"10.1016","volume":"54","author":[{"given":"Fatima","family":"Afaar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Matar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woojin S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenda M.","family":"Halliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J.G.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9121-0294","authenticated-orcid":false,"given":"Nicolas","family":"Dzamko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbih.2026.101257_bib1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12974-019-1606-1","article-title":"Regulatory impairment in untreated Parkinson's disease is not restricted to Tregs: other regulatory populations are also involved","volume":"16","author":"Alvarez-Luquin","year":"2019","journal-title":"J. Neuroinflammation"},{"issue":"8","key":"10.1016\/j.bbih.2026.101257_bib2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.parkreldis.2005.07.005","article-title":"Alterations of T-lymphocyte populations in Parkinson disease","volume":"11","author":"Baba","year":"2005","journal-title":"Parkinsonism Relat. Disorders"},{"issue":"3","key":"10.1016\/j.bbih.2026.101257_bib3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0753-3322(99)80079-1","article-title":"IL-1 beta, IL-2, IL-6 and TNF-alpha production by peripheral blood mononuclear cells from patients with Parkinson's disease","volume":"53","author":"Bessler","year":"1999","journal-title":"Biomed. Pharmacother."},{"issue":"s1","key":"10.1016\/j.bbih.2026.101257_bib4","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.3233\/JPD-223152","article-title":"T lymphocytes in Parkinson's Disease","volume":"12","author":"Contaldi","year":"2022","journal-title":"J. Parkinsons Dis."},{"issue":"1","key":"10.1016\/j.bbih.2026.101257_bib5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/mds.28137","article-title":"CD4+ T-cell transcription factors in idiopathic REM sleep behavior disorder and Parkinson's Disease","volume":"36","author":"De Francesco","year":"2021","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.bbih.2026.101257_bib6","doi-asserted-by":"crossref","first-page":"NS20220063","DOI":"10.1042\/NS20220063","article-title":"Cytokine activity in Parkinson's disease","volume":"7","author":"Dzamko","year":"2023","journal-title":"Neuronal Signaling"},{"key":"10.1016\/j.bbih.2026.101257_bib7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neuroscience.2014.10.028","article-title":"Inflammation is genetically implicated in Parkinson's disease","volume":"302","author":"Dzamko","year":"2015","journal-title":"Neuroscience"},{"issue":"10","key":"10.1016\/j.bbih.2026.101257_bib8","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020858118","article-title":"Monocyte markers correlate with immune and neuronal brain changes in REM sleep behavior disorder","volume":"118","author":"Farmen","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"568\u201378","key":"10.1016\/j.bbih.2026.101257_bib9","article-title":"The Farnsworth\u2013Munsell 100-hue test and dichotomous tests for color vision","volume":"33","author":"Farnsworth","year":"1943","journal-title":"J. Opt. Soc. Am."},{"key":"10.1016\/j.bbih.2026.101257_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.smrv.2018.09.008","article-title":"The risk of neurodegeneration in REM sleep behavior disorder: a systematic review and meta-analysis of longitudinal studies","volume":"43","author":"Galbiati","year":"2019","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.bbih.2026.101257_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2025.156954","article-title":"The role of interleukin (IL)-2 cytokine family in Parkinson's disease","volume":"191","author":"Goleij","year":"2025","journal-title":"Cytokine"},{"issue":"721","key":"10.1016\/j.bbih.2026.101257_bib12","doi-asserted-by":"crossref","first-page":"eadk3225","DOI":"10.1126\/scitranslmed.adk3225","article-title":"Central and peripheral innate and adaptive immunity in Parkinson's disease","volume":"15","author":"Harms","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"11","key":"10.1016\/j.bbih.2026.101257_bib13","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/mdc3.70210","article-title":"Plasma neurofilament light chain and TNF-alpha correlate with motor features in isolated REM sleep behavior disorder","volume":"12","author":"Huxford","year":"2025","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"8","key":"10.1016\/j.bbih.2026.101257_bib14","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s10072-017-2988-4","article-title":"The correlation of lymphocyte subsets, natural killer cell, and Parkinson's disease: a meta-analysis","volume":"38","author":"Jiang","year":"2017","journal-title":"Neurol. Sci."},{"issue":"9996","key":"10.1016\/j.bbih.2026.101257_bib15","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.bbih.2026.101257_bib16","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/mds.27841","article-title":"Peripheral blood inflammatory cytokines in idiopathic REM sleep behavior disorder","volume":"34","author":"Kim","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbih.2026.101257_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.parkreldis.2020.09.041","article-title":"Serum TNF-alpha and neurodegeneration in isolated REM sleep behavior disorder","volume":"81","author":"Kim","year":"2020","journal-title":"Parkinsonism Relat. Disorders"},{"issue":"4","key":"10.1016\/j.bbih.2026.101257_bib18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/jnnp-2017-317134","article-title":"Peripheral inflammation in prodromal Alzheimer's and Lewy body dementias","volume":"89","author":"King","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.bbih.2026.101257_bib19","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0022-510X(95)00180-A","article-title":"Defective production of interleukin-2 in patients with idiopathic Parkinson's disease","volume":"133","author":"Kluter","year":"1995","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.bbih.2026.101257_bib20","first-page":"222","article-title":"\"Sniffin' sticks\": screening of olfactory performance","volume":"34","author":"Kobal","year":"1996","journal-title":"Rhinology"},{"issue":"1","key":"10.1016\/j.bbih.2026.101257_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12974-018-1248-8","article-title":"Parkinson's disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1\/Th2\/T17 and Treg in drug-naive and drug-treated patients","volume":"15","author":"Kustrimovic","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.bbih.2026.101257_bib22","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12974-022-02481-3","article-title":"Parkinson's disease peripheral immune biomarker profile: a multicentre, cross-sectional and longitudinal study","volume":"19","author":"Li","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.bbih.2026.101257_bib23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1515\/nipt-2022-0001","article-title":"Interleukin-2 expands neuroprotective regulatory T cells in Parkinson's disease","volume":"1","author":"Markovic","year":"2022","journal-title":"NeuroImmune Pharm Ther."},{"issue":"Suppl. 6","key":"10.1016\/j.bbih.2026.101257_bib24","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/mds.10559","article-title":"Clinical overview of the synucleinopathies","volume":"18","author":"Marti","year":"2003","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.bbih.2026.101257_bib25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/17576180.2024.2442190","article-title":"Comparison of highly sensitive, multiplex immunoassay platforms for streamlined clinical cytokine quantification","volume":"17","author":"McKinski","year":"2025","journal-title":"Bioanalysis"},{"issue":"8","key":"10.1016\/j.bbih.2026.101257_bib26","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1474-4422(21)00176-9","article-title":"Biomarkers of conversion to alpha-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder","volume":"20","author":"Miglis","year":"2021","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.bbih.2026.101257_bib27","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41531-025-01146-1","article-title":"Recommendations for clinical study protocols for immune and inflammatory profiling in Parkinson's disease","volume":"11","author":"Munoz-Delgado","year":"2025","journal-title":"npj Parkinson's Dis."},{"issue":"3","key":"10.1016\/j.bbih.2026.101257_bib28","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/brain\/awz030","article-title":"Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study","volume":"142","author":"Postuma","year":"2019","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.bbih.2026.101257_bib29","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/brain\/awz030","article-title":"Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study","volume":"142","author":"Postuma","year":"2019","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.bbih.2026.101257_bib30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41531-023-00449-5","article-title":"A systematic review and meta-analysis of inflammatory biomarkers in Parkinson's disease","volume":"9","author":"Qu","year":"2023","journal-title":"npj Parkinson's Dis."},{"key":"10.1016\/j.bbih.2026.101257_bib31","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3389\/fneur.2020.00610","article-title":"A neurologist's guide to REM sleep behavior disorder","volume":"11","author":"Roguski","year":"2020","journal-title":"Front. Neurol."},{"issue":"10","key":"10.1016\/j.bbih.2026.101257_bib32","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1093\/brain\/awae177","article-title":"The immune system in Parkinson's disease: what we know so far","volume":"147","author":"Roodveldt","year":"2024","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.bbih.2026.101257_bib33","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/mds.29767","article-title":"Microglial activation and progression of nigrostriatal dysfunction in isolated REM sleep behavior disorder","volume":"39","author":"Staer","year":"2024","journal-title":"Mov. Disord."},{"issue":"16","key":"10.1016\/j.bbih.2026.101257_bib34","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1002\/mds.21740","article-title":"The REM sleep behavior disorder screening questionnaire--a new diagnostic instrument","volume":"22","author":"Stiasny-Kolster","year":"2007","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.bbih.2026.101257_bib35","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S1474-4422(17)30173-4","article-title":"Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study","volume":"16","author":"Stokholm","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbih.2026.101257_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2025.1682006","article-title":"Peripheral-central immune interactions in Parkinson's disease: insights into innate and adaptive immunity","volume":"18","author":"Tumpa","year":"2025","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bbih.2026.101257_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105700","article-title":"Immune responses in the Parkinson's disease brain","volume":"168","author":"Weiss","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbih.2026.101257_bib38","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.parkreldis.2020.07.017","article-title":"Plasma immune markers in an idiopathic REM sleep behavior disorder cohort","volume":"78","author":"Zhang","year":"2020","journal-title":"Parkinsonism Relat. Disorders"},{"issue":"7","key":"10.1016\/j.bbih.2026.101257_bib39","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/mds.29798","article-title":"Alterations of peripheral lymphocyte subsets in isolated rapid eye movement sleep behavior disorder","volume":"39","author":"Zheng","year":"2024","journal-title":"Mov. Disord."}],"container-title":["Brain, Behavior, &amp; Immunity - Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666354626000906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666354626000906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:07:44Z","timestamp":1781050064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666354626000906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":39,"alternative-id":["S2666354626000906"],"URL":"https:\/\/doi.org\/10.1016\/j.bbih.2026.101257","relation":{},"ISSN":["2666-3546"],"issn-type":[{"value":"2666-3546","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced serum interleukin-2 associates with higher motor severity and along with CD4 T cell alterations may be an early event in isolated REM Sleep Behaviour Disorder","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, & Immunity - Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbih.2026.101257","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101257"}}